IFS Advisors’s Gilead Sciences GILD Stock Holding History

IFS Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.43K	Hold	24	–	–	﹤0.01%	162
2025 Q4	$3K	Hold	24	–	–	﹤0.01%	146
2025 Q3	$2.7K	Hold	24	–	–	﹤0.01%	140
2025 Q2	$2.68K	Buy	24 +1	+4%	+$106	﹤0.01%	133
2025 Q1	$2.69K	Hold	23	–	–	﹤0.01%	153
2024 Q4	$2.2K	Hold	23	–	–	﹤0.01%	145
2024 Q3	$1.98K	Hold	23	–	–	﹤0.01%	124
2024 Q2	$1.6K	Hold	23	–	–	﹤0.01%	122
2024 Q1	$1.69K	Buy	23 +1	+5%	+$77	﹤0.01%	120
2023 Q4	$1.85K	Hold	22	–	–	﹤0.01%	114
2023 Q3	$1.7K	Hold	22	–	–	﹤0.01%	111
2023 Q2	$1.73K	Hold	22	–	–	﹤0.01%	108
2023 Q1	$1.84K	Hold	22	–	–	0.01%	84
2022 Q4	$1.89K	Buy	22 +1	+5%	+$79	﹤0.01%	93
2022 Q3	$1K	Hold	21	–	–	﹤0.01%	91
2022 Q2	$1K	Hold	21	–	–	﹤0.01%	91
2022 Q1	$1K	Hold	21	–	–	﹤0.01%	101
2021 Q4	$1K	Buy	+21	New	+$1.45K	﹤0.01%	108
2021 Q1	–	Sell	-20	Closed	-$1K	–	65
2020 Q4	$1K	Buy	+20	New	+$1.21K	﹤0.01%	155

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

IFS Advisors's GILD Position: Q1 2026 in Review

IFS Advisors held its Gilead Sciences (GILD) position steady in Q1 2026 at 24 shares worth $3.43K. The position accounts for ﹤0.01% of the portfolio, ranked #162.

IFS Advisors first reported a position in GILD in Q4 2020 and has held it in 19 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

IFS Advisors held 24 shares of Gilead Sciences worth $3.43K as of Q1 2026.
IFS Advisors left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up ﹤0.01% of IFS Advisors's portfolio in Q1 2026, its #162 holding.
IFS Advisors first reported a position in Gilead Sciences in Q4 2020 and has held it in 19 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on IFS Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.